Citi, Appointed

Citi, acting through Citibank N.A., has been appointed by Orchard Therapeutics plc (“Orchard”) as depositary bank for its American Depositary Receipt (“ADR”) programme.

06.11.2018 - 11:16:27

Citi Appointed as Depositary Bank for Orchard Therapeutics’ ADR Programme

For more information on Citi’s Depositary Receipt Services, visit

About Citi

Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.

Additional information may be found at | Twitter: @Citi | YouTube: | Blog: | Facebook: | LinkedIn:

About Orchard Therapeutics

Orchard Therapeutics is a fully integrated commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies. Orchard’s advanced portfolio of autologous ex vivo gene therapies targets serious and life-threatening rare diseases, initially primary immune deficiencies, neurometabolic disorders and hemoglobinopathies.